Straumann Group (STMN) CMD 2025 summary

Strategic vision and market opportunity

• Targeting a $20 billion under-penetrated dental market with ambitions for 10% CAGR revenue growth and 40–50 basis point annual EBIT margin expansion from 2026 to 2030 at constant FX rates.

• Aims to be the most innovative, customer-focused, digitally powered oral care company globally, targeting 10 million smiles by 2030 and double-digit CAGR growth.

• Focused on both core implant business and new growth segments: clear aligners, digital equipment, and chairside prosthetics, leveraging innovation and digitalization.

• Multi-brand and multi-geography strategy, with strong positions in EMEA, North America, APAC, and Latin America, and a resilient, diversified supply chain.

• Anticipates continued benefit from demographic trends, rising affordability, and increasing demand for high-end dental treatments, especially in emerging markets.

Progress and performance

• Achieved 16.2% CAGR in net revenue (2021–2024) and 18.5% CAGR in EBIT, with EBIT margin improving to 32.4% at constant FX, outpacing market growth and exceeding prior targets.

• Implantology market share increased from 29% to 35% between 2021 and 2024.

• 6.7 million smiles created and high employee engagement scores achieved.

• Margin expansion driven by operational excellence, local-for-local production, procurement initiatives, and digital transformation.

• FX headwinds, especially from the Swiss franc, have impacted reported margins, but transactional FX is fully hedged; focus on reducing Swiss cost base and increasing local production.

Growth strategy and innovation

• Growth playbook focuses on expanding implant leadership, transforming the ortho franchise, and disrupting prosthetics through digitalization.

• Digital transformation is central, with the AXS/Straumann Access cloud platform enabling end-to-end digital workflows, AI-driven planning, and recurring revenue streams.

• Clear aligner business (ClearCorrect) undergoing transformation via a technology and manufacturing partnership with Smartee, aiming for double-digit market share in the GP segment by 2030.

• Digital equipment and chairside prosthetics positioned for rapid growth, with new products (e.g., Sirius X3 scanner, SprintRay Midas 3D printer) and integrated workflows.

• Education and customer support remain central, with large-scale training initiatives and tailored programs for DSOs and GPs to drive adoption of new technologies.